Skip to main content

Dr. Christopher K. Lippincott, M.D.

Internal Medicine (Internal Medicine Physician)

  • Medicare participating

At a glance

Years since graduation
20
In the NPI registry since
2007
Medicare patients seen, 2024
236

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Medical school: University of Virginia School of Medicine
  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Internal Medicine Physician primary
    MD license D79961
  • Infectious Disease Physician
    MD license D79961

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Internal Medicine per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
236
Services billed
803
Patients’ average age
71
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes14589
Established patient office or other outpatient visit, 40-54 minutes11684
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes8077
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes7854
Established patient office or other outpatient visit, 30-39 minutes4840
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes3636
New patient office or other outpatient visit, 60-74 minutes2828
Established patient office or other outpatient visit, 20-29 minutes2319
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or1513

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Ethambutol Hcl66
Biktarvy (bictegrav/emtricit/tenofov ala)43
Azithromycin
Other prescribers in Baltimore, MD
40
Arikayce (amikacin liposomal/neb.accessr)38
Albuterol Sulfate Hfa (albuterol sulfate)
Other prescribers in Baltimore, MD
28
Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav)
Other prescribers in Baltimore, MD
28
Nuzyra (omadacycline tosylate)27
Dovato (dolutegravir sodium/lamivudine)22
Tivicay (dolutegravir sodium)22
Rosuvastatin Calcium
Other prescribers in Baltimore, MD
20

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 2 companies reported 17 payments worth $16,699 in total to this clinician.

By company
Paratek Pharmaceuticals, Inc.$9,020
Insmed, Inc.$7,679
By type
Consulting Fee$13,760
Travel and Lodging$2,244
Food and Beverage$695

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
May 20, 2025Paratek Pharmaceuticals, Inc.
May 20, 2025
Consulting Fee
NUZYRA · ANTIBIOTIC
$7,910
May 8, 2025Insmed, Inc.
May 8, 2025
Consulting Fee$5,850
Mar 28, 2025Insmed, Inc.
Mar 28, 2025
Travel and Lodging
travel to Austin, TX · in-kind
$852
May 20, 2025Paratek Pharmaceuticals, Inc.
May 20, 2025
Travel and Lodging
NUZYRA · ANTIBIOTIC · travel to DENVER, CO
$436
Apr 4, 2025Insmed, Inc.
Apr 4, 2025
Travel and Lodging
travel to Austin, TX · in-kind
$347
Apr 7, 2025Paratek Pharmaceuticals, Inc.
Apr 7, 2025
Travel and Lodging
NUZYRA · ANTIBIOTIC · travel to DENVER, CO · in-kind
$288
Apr 7, 2025Insmed, Inc.
Apr 7, 2025
Travel and Lodging
travel to Austin, TX · in-kind
$193
Apr 8, 2025Insmed, Inc.
Apr 8, 2025
Travel and Lodging
travel to Austin, TX · in-kind
$128

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Maryland →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $39,640 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Internal Medicine clinicians in Baltimore

Sources

NPI registry (CMS NPPES, November 2026; record last updated May 9, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1306059019. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.